Homepage
Catalog of Screening Compounds
Screening Libraries
Focused and Target Libraries
Active Reference Sets
Diversity Libraries
Screening Compounds
Building blocks
Drug Discovery Services
Custom Chemistry
Medicinal chemistry
In silico Drug Design (CADD)
Discovery Biology
Animal Models
Toxicology and Safety
ADME, DMPK
Chemistry, Manufacturing and Controls
Company
News & Media
Contact us
For suppliers
Trends in discovery compounds
Homepage
>
Company
>
Media
>
Pharma News
Pharma News
U.S. Children Ages 12 to 15 Could Begin COVID-19 Vaccinations Thursday
U.
New theory may revolutionize treatment of endometriosis
Endometriosis, a disease found in up to 10 per cent of women, has been enigmatic since it was first described.
Lonza Announces Expansion Plans for Next-Generation Mammalian Manufacturing Facilities in Visp (CH) and Portsmouth (US)
Basel, Switzerland, 7 May 2021 – Lonza today announced significant investments to expand its mammalian drug substance manufacturing facilities in Visp (CH) and Portsmouth (US).
Vectura, Inspira team up to develop inhaled COVID-19 drug
Contract development and manufacturing organisation (CDM) Vectura Group and Inspira Pharmaceuticals, a new UK-based company focused on developing therapies for respiratory and infectious disea...
WHO grants Sinopharm’s COVID-19 vaccine emergency approval
The World Health Organization (WHO) has approved Sinopharm’s COVID-19 vaccine for emergency use, making it the first jab developed by a non-Western company to gain this recommendation.
Orphazyme announces topline data from pivotal trial of arimoclomol in Amyotrophic Lateral Sclerosis (ALS)
COPENHAGEN, Denmark I May 8, 2021 I Orphazyme A/S (ORPHA.
First genetically modified mosquitoes released in US
The biotech firm Oxitec has released its genetically modified mosquitoes in the Florida Keys, with the goal of suppressing wild, disease-carrying mosquito populations in the region.
Pfizer/BioNTech seek full FDA approval for their Covid-19 vaccine
(CNN)Pfizer/BioNTech has initiated its application to the US Food and Drug Administration for full FDA approval of its Covid-19 vaccine for people ages 16 and older, the companies said Friday.
FDA grants accelerated approval to pembrolizumab for HER2-positive gastric cancer
On May 5, 2021, the Food and Drug Administration granted accelerated approval to pembrolizumab (Keytruda, Merck & Co.
FDA extends tie-up with CN Bio to test ‘lung-on-a-chip’ tech
The FDA has extended a collaboration with the UK firm CN Bio to investigate a “lung-on-a-chip” model to investigate inhaled drugs.
US supports waiving IP for COVID vaccines
The Biden-Harris Administration has voiced support for waiving intellectual property protections for COVID vaccines, in the hope of ramping up access in low-income countries hit by the virus, marking ...
Tecentriq approved for first-line metastatic NSCLC
Roche’s checkpoint inhibitor Tecentriq has gained a new approval from the European Commission, for the first-line treatment of certain patients with metastatic non-small cell lung cancer (NSCLC&...
230
231
232
233
234
235
236
237
238
